Mako Yamamoto

In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration

Keiichiro Suzuki, Yuji Tsunekawa, Reyna Hernández‐Benítez et al. · Nature · 2016 · 1.2K citations · Full text

Life Sciences, Genetics, Molecular Biology +10

In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice

Kristen Browder, Pradeep Reddy, Mako Yamamoto et al. · Nature Aging · 2022 · 239 citations

Life Sciences, Genetics, Molecular Biology +12

Single-dose CRISPR–Cas9 therapy extends lifespan of mice with Hutchinson–Gilford progeria syndrome

Ergin Beyret, Hsin‐Kai Liao, Mako Yamamoto et al. · Nature Medicine · 2019 · 159 citations

Life Sciences, Genetics, Molecular Biology +10

In vivo reprogramming of wound-resident cells generates skin epithelial tissue

Masakazu Kurita, Toshikazu Araoka, Tomoaki Hishida et al. · Nature · 2018 · 147 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +16

Efficacy of tumor-targeting <i>Salmonella typhimurium</i> A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models

Yukihiko Hiroshima, Yong Zhang, Takashi Murakami et al. · Oncotarget · 2014 · 129 citations · Full text

Medicine, Oncology, Pharmacology +17